Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.

There was a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with Type 2 diabetes from 2021-23.

DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies' market shares, challenges, diabetes ...

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

But as these products proliferate, manufacturers face a new set of questions. How do expectations around comfort, usability, ...

The study was carried out at 24 clinical sites across the UK and included 303 participants.

A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of ...

Researchers have found in a new study that continuous glucose monitoring (CGM) in the ICU appears to provide reliable glucose ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.